Clinical Trials Browser

Phase 2 × naloxegol × Thoracic × Clear all

NCT03087708 2025-07-17

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Phase 2 Terminated

50 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung